Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Entero Healthcare Solutions Limited (ENTERO.NS)
INR1,231.10
-10.50 (-0.85%)
IN NSE Healthcare Medical - Distribution
Address
Trade Centre, Bandra Kurla Complex 400051
Mumbai, IN
Mumbai, IN
CEO
Prabhat Agrawal
Website
enterohealthcare.com
IPO
2024-02-16
ISIN INE010601016
Description
Established in 2018 and headquartered in Mumbai, India, Entero Healthcare Solutions Limited functions as a key distributor within the Indian healthcare sector. The company specializes in supplying a diverse range of medical and health-related products, including pharmaceuticals, surgical instruments, medical equipment, over-the-counter remedies, nutritional supplements, and vaccines. Its extensive client base spans retail pharmacies, hospitals, nursing homes, and various healthcare clinics throughout the country.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
INR1,231.10
-10.50 (-0.85%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
126.8K
Beta
-0.63
Float Shares
32.69M
Free Float %
75.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.88% | +1.70% | +2.67% | +20.93% | +22.23% | +25.02% | -13.12% | +11.65% | +11.65% | +11.65% | +11.65% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1,231.10
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
4.16
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Distribution: +5.6%+29.4% ★ Q1'26: +42.6% (vs Q1'25)
-
EPS growth Medical - Distribution: +4.9%+21.3% ★ Q1'26: +9.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Distribution: +37.6%0.0% Q1'26: -3.6% (vs Q1'25)
-
EBIT margin Medical - Distribution: +3.0%+3.4% ★ Q1'26: +3.7% (vs Q1'25)
-
ROIC Medical - Distribution: +5.7%+8.5% ★ Q1'26: +10.4% (vs Q1'25)
-
Share dilution Medical - Distribution: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Distribution: 0.87×2.55× Q1'26: 1.97× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 3 EPS Ana. |
Mar 2027 3 Rev. Ana. 3 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
39.22B
est: 41.32B (-5.1%)
|
50.96B
est: 51.71B (-1.5%)
|
64.80B
64.76B – 64.84B
+25.3% YoY
|
80.05B
78.73B – 82.60B
+23.5% YoY
|
97.74B
97.32B – 98.15B
+22.1% YoY
|
| EBITDA |
1.26B
est: 3.23B (-60.9%)
|
2.11B
est: 4.04B (-47.7%)
|
5.06B
5.06B – 5.06B
+25.3% YoY
|
6.25B
6.15B – 6.45B
+23.5% YoY
|
7.63B
7.60B – 7.66B
+22.1% YoY
|
| EBIT |
1.01B
est: 3.13B (-67.6%)
|
1.80B
est: 3.91B (-53.9%)
|
4.90B
4.90B – 4.91B
+25.3% YoY
|
6.06B
5.96B – 6.25B
+23.5% YoY
|
7.40B
7.36B – 7.43B
+22.1% YoY
|
| Net Income |
391.09M
est: 605.58M (-35.4%)
|
948.20M
est: 1.03B (-7.5%)
|
1.39B
1.37B – 1.62B
+35.3% YoY
|
1.92B
1.81B – 2.11B
+38.4% YoY
|
2.51B
2.47B – 2.76B
+30.9% YoY
|
| SGA |
1.56B
est: 922.00M (+69.5%)
|
1.16B
est: 1.15B (+0.3%)
|
1.45B
1.45B – 1.45B
+25.3% YoY
|
1.79B
1.76B – 1.84B
+23.5% YoY
|
2.18B
2.17B – 2.19B
+22.1% YoY
|
| EPS |
10.81
est: 13.77 (-21.5%)
|
21.81
est: 23.77 (-8.2%)
|
33.10
31.54 – 37.15
+39.2% YoY
|
46.10
41.46 – 48.41
+39.3% YoY
|
60.60
56.68 – 63.35
+31.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-293.69M
OE per share TTM
-6.73
Owner's Yield
-0.53%
Maintenance CapEx ratio
4.90%
Maint CapEx / Avg PPE
3.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 14 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI India Small-Cap ETF SMIN | 0.05% | 398.4K | 0.74% |
| 2 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.01% | 42.2K | 0.74% |
| 3 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 73.7K | 0.65% |
| 4 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.01% | 50.8K | 0.55% |
| 5 | State Street SPDR Portfolio MSCI Global Stock Market ETF SPGM | 0.00% | 87.5K | 0.09% |
| 6 | iShares Core MSCI EM IMI UCITS ETF EIMI.L | 0.00% | 447.5K | 0.18% |
| 7 | iShares Core MSCI EM IMI UCITS ETF EIMU.L | 0.00% | 18.4K | 0.18% |
| 8 | iShares Core MSCI Emerging Markets IMI Index ETF XEC.TO | 0.00% | 32.4K | 0.28% |
| 9 | iShares Core MSCI All-Country World ex Canada Index ETF XAW.TO | 0.00% | 4.1K | 0.22% |
| 10 | iShares Core Equity ETF Portfolio XEQT.TO | 0.00% | 7.1K | 0.20% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
687.2K
Shares Outstanding
43.51M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Prabhat Agrawal | Co-Founder, Chief Executive Officer, MD & Director | 44M | male |
| Prem Sethi | Co-Founder, Chief Operating Officer & Whole-time Director | 24M | male |
| Abhitesh Kumar | Chief Growth Officer | — | male |
| Balakrishnan Natesan Kaushik | Group Chief Financial Officer | — | male |
| Sambit Mohanty | President of Institutional Business | — | male |
| Sanu Vishal Kapoor | Vice President of Legal and General Counsel, Company Secretary & Compliance Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ENTERO.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
